International

AccessBio CareStart Mid-Nasal Rapid Diagnostic Antigen Test

Category
Name
AccessBio CareStart Mid-Nasal Rapid Diagnostic Antigen Test
Category
Note
Professional Use Only.

Product has expiration date.

FDA Emergency Use Authorization Letter

Fact Sheet for Healthcare Providers

Fact Sheet for Patients

Regulatory Status: FDA EUA Authorized – this test has not been FDA cleared or approved
Contents: (20) Sealed Test Devices, (20) Assay Buffer, (20) Extraction Vials and Caps, (20) Specimen Collection Swabs, (1) Positive and (1) Negative Control Swabs , (1) Instructions for Use
Determinations: Detection of the SARS-CoV-2 nucleocapsid protein antigen
Storage Requirements: 34° – 86° F
Processing Time: Approximately 10 Minutes

Intended to be a point-of-care (POC) test, the CareStart COVID-19 Antigen Rapid Test has a 10 minute processing time and allows effective screening of COVID-19 infection on a large scale without the use of a separate analyzer.

Minimally invasive specimen collection (anterior nasal or nasopharyngeal)
Lateral flow assay
Rapid results in 10 minutes (do not read after 15 minutes)
Intended for point-of-care settings by medical professionals
CLIA waived
For in vitro diagnostic use only
Prescription use only
This will detect the current European mutations as well!
Categories